Medicine
fromScienceDaily
10 hours agoWomen over 50 lost 35% more weight with this surprising combo
Menopausal hormone therapy combined with tirzepatide significantly enhances weight loss in postmenopausal women.
People who stop using the weight-loss jab Mounjaro not only tend to regain weight, but experience a reversal in other health improvements too, research suggests. Mounjaro, which contains the active ingredient tirzepatide, has become a popular medication for weight loss, with studies suggesting that it can help people lose an average of 20% of their body weight after 72 weeks of treatment.
More time using electronic devices or watching TV among children and young adults was linked with higher cardiometabolic disease risk, including high blood pressure, high cholesterol and insulin resistance, based on data from more than 1,000 participants in Denmark. The association between screen time and cardiometabolic risks was strongest in youth who slept fewer hours, suggesting that screen use may harm health by "stealing" time from sleep, researchers said.